1-(3-IodoMethyl-piperidin-1-yl)-ethanone
![]() |
- $323.73 - $882.36
- Product name: 1-(3-IodoMethyl-piperidin-1-yl)-ethanone
- CAS: 181999-37-1
- MF: C8H14INO
- MW: 267.11
- EINECS:
- MDL Number:MFCD21097886
- Synonyms:1-(3-IodoMethyl-piperidin-1-yl)-ethanone;Ethanone, 1-[3-(iodomethyl)-1-piperidinyl]-;1-[3-(iodomethyl)-1-piperidyl]ethanone
5 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 250mg
- 1g
- ManufacturerAlichem
- Product number181999371
- Product description1-(3-(Iodomethyl)piperidin-1-yl)ethanone
- Packaging250mg
- Price$323.73
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number181999371
- Product description1-(3-(Iodomethyl)piperidin-1-yl)ethanone
- Packaging1g
- Price$882.36
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM300814
- Product description1-(3-(iodomethyl)piperidin-1-yl)ethanone 95%
- Packaging1g
- Price$683
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11181289
- Product description1-(3-(Iodomethyl)piperidin-1-yl)ethanone 97%
- Packaging250mg
- Price$327
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11181289
- Product description1-(3-(Iodomethyl)piperidin-1-yl)ethanone 97%
- Packaging1g
- Price$817
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 181999371 | 1-(3-(Iodomethyl)piperidin-1-yl)ethanone | 250mg | $323.73 | 2021-12-16 | Buy |
Alichem | 181999371 | 1-(3-(Iodomethyl)piperidin-1-yl)ethanone | 1g | $882.36 | 2021-12-16 | Buy |
Chemenu | CM300814 | 1-(3-(iodomethyl)piperidin-1-yl)ethanone 95% | 1g | $683 | 2021-12-16 | Buy |
Crysdot | CD11181289 | 1-(3-(Iodomethyl)piperidin-1-yl)ethanone 97% | 250mg | $327 | 2021-12-16 | Buy |
Crysdot | CD11181289 | 1-(3-(Iodomethyl)piperidin-1-yl)ethanone 97% | 1g | $817 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|